NCT06269445View on ClinicalTrials.gov

The Efficacy and Safety of Lcaritin Combined With Bevacizumab and FOLFIRI in Treatment of Liver Metastases From Colorectal Cancer

PHASE4RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

February 1, 2025

Study Completion Date

February 1, 2026

Conditions
Colorectal Cancer
Interventions
DRUG

Icaritin Combined With Bevacizumab and FOLFIRI

Bevacizumab and FOLFIRI are second-line treatment options for colorectal cancer; synergistic efficacy expected in combination with Icaritin

Trial Locations (1)

310000

RECRUITING

Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
lead

Sir Run Run Shaw Hospital

OTHER